期刊文献+

靶向于前列腺癌特异性膜抗原shRNA的筛选与鉴定 被引量:2

Selection and identification of shRNA sequences targeting the prostate cancer-specific membrane antigen
原文传递
导出
摘要 目的获得高效抑制前列腺癌细胞株Lncap中前列腺癌特异性膜抗原(PSMA)表达的shRNA序列。方法根据PSMA基因信息,设计siRNA1、siRNA2、siRNA3三条针对PSMA基因cds区的siRNA序列及无意义的对照序列,组建与之对应的4对互补的单链DNA序列,包括siRNA的正义链和反义链;正义链序列按5’向3’顺序依次为:酶切位点(BamHⅠ)、干扰序列(19bp)、loop环(TTCAAGAGA)、干扰序列的反向互补序列(19bp)、中止信号(TTTTT)、酶切位点(EcoRⅠ)。将合成的序列插入空载体pSIH1-H1-copGFP shRNA Vector中,转染前列腺癌细胞后,通过real-time PCR检测不同序列片段对PSMA的mRNA抑制效果并通过Western blot检测对目的蛋白PSMA的抑制效果。结果设计的3条针对PSMA的序列中第2条的抑制效果最好,目的序列位于PSMA(NM_0004476)的1207到1226,茎环序列为5’-GATCC GTCTCAAAGTGCCCTACAA TTCAAGAGA TFGTAGGGCACTTTGAGAC TTTTT G-3’。其对前列腺癌细胞株中PSMA的mRNA的抑制率为60.0%,对其蛋白表达的抑制率为86%。转染细胞后,细胞可以稳定低表达PSMA。结论成功获得高效抑制前列腺癌细胞株Lncap中PSMA表达的shRNA序列。 Objective To obtain shRNA sequences that can block the expression of prostate cancer-specific membrane antigen (PSMA) in the prostate cancer cell line Lncap with high quality. Methods According to PSMA genetic information, siRNA1, siRNA2, siRNA3 and negative sequences, and those three siRNA sequences targeting the cds area of PSMA gene were designed and then the corresponding four pairs of complementary single strand DNA of shRNA ,including the sense strand and the antisense strand ,were formed. The sequence of sense strand from 5' to 3' was:enzyme digestion site (BamH Ⅰ) ,interference sequence (19 bp), the loop-stem structure (TTCAAGAGA), the reverse complementary sequence of interference sequence ( 19 bp) , the ending signal (TTTTT) , enzyme digestion site ( EcoR Ⅰ ). The synthetic shRNA sequence was inserted into the empty pSIH1-H1-copGFP shRNA vector, and after transfecting the prostate cancer cells ,the inhibitory effect of PSMA mRNA by different sequences was detected by using real-time PCR, and the inhibitory effect of PSMA protein expression was detected by Western-blotting. Highly effective shRNA sequences inhibiting PSMA expression in prostate cancer cells could be obtained. Results The second shRNA sequence had the best inhibitory effect. Its position located in PSMA (NM_004476) 1207-1226 and its stem-loop sequence was 5 '-GATCC GTCTCAAACTGCCCTACAA TTCAAGAGA TTGTAGGGCACTTTGAGAC TTTTT G-3 '. The inhibitory rate of PSMA mRNA and protein in prostate cancer cell line was 60.0% and 86% respectively. After transfection ,the prostate cancer cell line had the low expression of PSMA stably. Conclusion shRNA sequences that can stably block the expression of PSMA is successfully obtained in the prostate cancer cell line Lncap.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2008年第9期1190-1192,共3页 Chinese Journal of Experimental Surgery
基金 广东省自然科学基金资助项目(001356、05100980、05300720)
关键词 前列腺癌 RNA干扰 抗原 Prostate carcinoma RNA interference Antigen
  • 相关文献

参考文献4

二级参考文献30

  • 1黄海,黄健,林天歆,许可慰,赵风进,潘秋辉,江春,韩金利.人前列腺特异性膜抗原cDNA的克隆、原核表达、鉴定和抗原初步纯化[J].中华泌尿外科杂志,2004,25(8):533-536. 被引量:6
  • 2黄海,黄健,潘秋辉,林天歆,郭正辉,许可慰,江春,韩金利.中国人前列腺特异性膜抗原基因的克隆及鉴定[J].中山大学学报(医学科学版),2005,26(1):84-87. 被引量:10
  • 3Israeli RS, Powell CT, Fair WR, et al. Molecular cloning of a complementary DNA encoding a prostatespecific membrane antigen[J]. Cancer Res, 1993, 53(2):227-30.
  • 4Carter RE, Feldman AR, CoyleJT. Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristic of a neuropeptidase [J].Proc Natl Acad Sci USA, 1996, 93(2): 749-53.
  • 5Gregorakis AK, Holmes EH, Murphy GP. Prostatespecific membrane antigen: current and future utility[J]. Semin Urol Oncol, 1998, 16 (1):2-12.
  • 6Chang SS, Reuter VE, Heston WD, et al. Five different prostate specific membrane antigen (PSMA) antibodies confirm PSMA expression in turmor associated neovasculature [J]. Cancer Res, 1999, 59(13): 3192-8.
  • 7Bostwich DG, Pacelli A, Blute M, et al. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases [J]. Cancer, 1998, 82(11): 2256-61.
  • 8Ross JS, Sheehan CE, Fisher HA, et al. Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer[J]. Clin Cancer Res, 2003, 9(17):6357-62.
  • 9Schmidt B, Anastasiadis AG, Seifert HH, et al.Detection of circulating prostate cells during radical prostatectomy by standardized PSMA RT-PCR:association with positive lymph nodes and high malignant grade [J]. AnticancerRes, 2003, 23(5A):3991-9.
  • 10Tino WT, Hubeer MJ, Lake TP, et al. Isolation and characterization of monoclonal antibodies specific for protein confirmational epitopes present in prostate specific membrane antigen [J]. Hybridoma, 2000, 19(3):249-57.

共引文献14

同被引文献6

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部